4 MAXE · 132 RUN
★ ★
Online, Self-Directed Courses for College Credits
P
TO T R A N S F O R M L I V E S A N D CO M M U N I T I E S BY P R O V I D I N G L E A R N I N G
EST. 2000
O P P O RT U N I T I E S F O R A L L W H O A S P I R E TO T H R I V E
EXAM 4 NUR 231 PHARM TEXTBOOK
P H A R M ACO LO G Y & C L I N I C A L J U D G M E N T
INSTITUTION Portage Learning COURSE CODE NUR 231
PROGRAM Bachelor of Science in Nursing ACADEMIC YEAR
EXAM TITLE EXAM 4 NUR 231 PHARM TOTAL QUESTIONS 80 Questions
TEXTBOOK
COURSE TITLE Pharmacology FORMAT Multiple Choice — Select the
Single Best Answer
EXAMINATION INSTRUCTIONS
▸ Select the single best answer for each question unless otherwise instructed.
▸ Drug classifications, mechanisms, adverse effects, and contraindications are all testable content.
▸ Population-specific contraindications and special patient safety considerations are emphasized.
▸ Correct answers and clinical rationales appear below each question for board review purposes.
▸ All pharmacological data reflects current evidence-based clinical guidelines.
, SECTION I — COMPREHENSIVE PHARMACOLOGY REVIEW Questions 1 – 80
1. Which concept does the nurse need to understand before administering a drug? Select all
that apply.
A. Drugs with a smaller volume of drug distribution have a longer half-life.
B. Oral drugs are dissolved through the process of pinocytosis.
C. Patients with kidney disease may have fewer protein-binding sites.
D. Rapid absorption decreases the bioavailability of the drug.
E. When the drug metabolism rate is decreased, toxicity can occur.
CORRECT ANSWER C, E — Patients with kidney disease may have fewer protein-binding sites;
when drug metabolism rate is decreased, toxicity can occur
RATIONALE Patients with kidney disease may have decreased serum albumin, resulting in
fewer protein-binding sites and increased free drug levels. Decreased drug
metabolism (e.g., hepatic impairment) can lead to drug accumulation and
toxicity. Rapid absorption actually increases bioavailability, and drugs with
smaller volume of distribution typically have shorter half-lives. Pinocytosis is not
the primary mechanism for oral drug dissolution.
2. The nurse prepares to administer medications. Which drug orders are complete? Select all
that apply.
A. Aspirin 81 mg PO daily
B. Multivitamin sustained
C. Vitamin D PO
D. Ciprofloxacin 500 mg PO tid
E. Promethazine 25 mg STAT
CORRECT ANSWER A, D — Aspirin 81 mg PO daily; Ciprofloxacin 500 mg PO tid
RATIONALE Complete drug orders must include: drug name, dose, route, and frequency.
Aspirin 81 mg PO daily includes all components. Ciprofloxacin 500 mg PO tid
includes drug, dose, route, and frequency. Multivitamin sustained lacks dose and
route. Vitamin D PO lacks dose and frequency. Promethazine 25 mg STAT lacks
route.
,3. Prioritize the steps of the Clinical Judgment Measurement Model [Nursing Process] in
correct order.
A. Generate Solutions [Planning]
B. Analyze Cues [Analysis]
C. Recognize Cues [Assessment]
D. Prioritize Hypothesis [Analysis]
E. Evaluate Outcomes [Evaluation]
F. Take Action [Intervention]
CORRECT ANSWER C, B, D, A, F, E — Recognize Cues → Analyze Cues → Prioritize Hypothesis →
Generate Solutions → Take Action → Evaluate Outcomes
RATIONALE The Clinical Judgment Measurement Model (CJMM) follows the nursing process in
this specific sequence: Assessment (Recognize Cues) → Analysis (Analyze Cues) →
Analysis (Prioritize Hypothesis) → Planning (Generate Solutions) →
Implementation (Take Action) → Evaluation (Evaluate Outcomes). This reflects
the correct clinical reasoning pathway for nursing practice.
4. The research nurse is meeting with a patient and determines the patient meets inclusion
criteria for clinical research. The patient agrees to participate in the clinical trial. The nurse
advises the patient that which member of the health care team has the responsibility to
explain the study and respond to questions?
A. Registered nurse
B. Pharmacist
C. Research associate
D. Health care provider
CORRECT ANSWER D — Health care provider
RATIONALE The health care provider (physician or principal investigator) has the ultimate
responsibility to explain the study protocol, risks, benefits, and respond to
questions during the informed consent process. While nurses may witness
signatures and provide support, the provider is legally responsible for ensuring
the patient understands the research study.
, 5. When developing an effective medication teaching plan, which component will the nurse
identify as most essential?
A. Written instructions
B. The patient's readiness to learn
C. Use of colorful charts
D. A review of community resources
CORRECT ANSWER B — The patient's readiness to learn
RATIONALE The patient's readiness to learn is the most essential component of an effective
medication teaching plan. Even the best teaching materials are ineffective if the
patient is not ready—physically, emotionally, or cognitively—to receive and
process information. Readiness to learn encompasses motivation, attention,
physical well-being, and mental state.
6. Which factor alerts the individual that a drug is counterfeit or adulterated? Select all that
apply.
A. Variations in packaging
B. Unexpected side effects
C. Different taste
D. Different chemical components
E. Different odor
CORRECT ANSWER A, B, C — Variations in packaging, unexpected side effects, different taste
RATIONALE Signs of counterfeit or adulterated drugs include variations in packaging
(inconsistent labeling, poor print quality), unexpected side effects (indicating
different active ingredients), and different taste from what is expected. While
different chemical components and odor are also potential indicators, the source
material specifically identifies variations in packaging, unexpected side effects,
and different taste as key alerting factors.